Manufacturer record
Vikram Laboratories (P) Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Vikram Laboratories (P) Ltd were declared Not of Standard Quality between April 2019 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 8563, Griseofulvin Tablets IP(GRISOVIK-250) (exp Apr 2026). State Lab Puducherry (state lab) found it not of standard quality: On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform with respect to the test for. Listed in the April 2025 alert.
Records by type
2 records linked to Vikram Laboratories (P) Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Griseofulvin Tablets IP(GRISOVIK-250) | Batch 8563Mfg May 2024 · Exp Apr 2026 | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform with respect to the test for Description.Description | State Lab PuducherryState lab | Apr 2025 |
| IBUPROFEN TABLETS IP 200 MG | Batch 5922Mfg Jun 2018 · Exp May 2020 | Test for DissolutionDissolution | CDTL ChennaiCDSCO lab | Apr 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.